Healthcare / Medical Care FacilitiesKuala Lumpur
$0.21
+0.00 (+2.44%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 18%
FCF escenarios
weak_data · normalized FCF $-2.8M · quality 43.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
44/100
C
Piotroski
4/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$175M
P/E
21.0x
↑EV/EBITDA
8.5x
↓ROE
9.7%
↑Gross Margin
46.1%
↓Debt/Equity
0.42
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+7.5%
FCF CAGR
—
FCF margin
-26.5%
FCF / Net income
-1.92x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $80.0M · net income $11.1M · FCF $-21.2M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $80.0M | $80.0M | $66.8M | $70.3M | $64.4M |
| Net Income | $11.1M | $11.1M | $11.1M | $13.3M | $9.4M |
| EBITDA | $24.9M | $24.9M | $21.3M | $21.3M | $17.4M |
| EPS | 0.01 | 0.01 | 0.01 | 0.02 | 0.01 |
| Gross Margin | 46.1% | 46.1% | 46.5% | 43.7% | 40.4% |
| Operating Margin | 18.5% | 18.5% | 19.8% | 20.6% | 18.0% |
| Net Margin | 13.8% | 13.8% | 16.6% | 18.9% | 14.6% |
| Balance Sheet | |||||
| Debt/Equity | 0.42 | 0.42 | 0.07 | 0.14 | 0.17 |
| Current Ratio | 3.93 | 3.93 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-21.2M | $-21.2M | $-2.8M | $11.8M | $14.9M |
| Returns | |||||
| ROE | 9.7% | 9.7% | 10.0% | 12.5% | 10.1% |
| Valuation | |||||
| P/E | 21.00 | 21.00 | 24.06 | 23.29 | 27.05 |
| EV/EBITDA | 8.46 | 8.46 | 12.79 | 15.22 | 15.27 |
| P/B | 1.53 | 1.53 | 2.40 | 2.92 | 2.74 |
| Growth & Yield | |||||
| Revenue Growth | 19.7% | 19.7% | -4.9% | 9.1% | — |
| EPS Growth | 0.0% | 0.0% | -17.4% | 10.3% | — |
| Dividend Yield | 3.1% | 3.1% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
11.9%
EPS terminal req.
$0.02
Spread vs growth
-11.9%
5Y implied EPS CAGR
11.1%
EPS terminal req.
$0.02
Spread vs growth
-11.1%
10Y implied EPS CAGR
10.6%
EPS terminal req.
$0.04
Spread vs growth
-10.6%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-12.9%
Start / end P/E
18.8x → 15.8x
EPS bridge
0.01 → 0.01
Residual
+0.0%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.